Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Gains from Investment Securities (2022 - 2025)

Historic Gains from Investment Securities for Core Laboratories (CLB) over the last 4 years, with Q3 2025 value amounting to -$286000.0.

  • Core Laboratories' Gains from Investment Securities rose 4684.01% to -$286000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $424000.0, marking a year-over-year increase of 21712.71%. This contributed to the annual value of $900907.0 for FY2024, which is 2402.8% up from last year.
  • According to the latest figures from Q3 2025, Core Laboratories' Gains from Investment Securities is -$286000.0, which was up 4684.01% from $351000.0 recorded in Q2 2025.
  • Core Laboratories' 5-year Gains from Investment Securities high stood at $1.3 million for Q4 2024, and its period low was -$917000.0 during Q1 2025.
  • Its 4-year average for Gains from Investment Securities is -$24461.5, with a median of -$99000.0 in 2024.
  • In the last 5 years, Core Laboratories' Gains from Investment Securities skyrocketed by 130377.36% in 2024 and then plummeted by 34068.24% in 2025.
  • Over the past 4 years, Core Laboratories' Gains from Investment Securities (Quarter) stood at $436000.0 in 2022, then tumbled by 124.31% to -$106000.0 in 2023, then skyrocketed by 1303.77% to $1.3 million in 2024, then plummeted by 122.41% to -$286000.0 in 2025.
  • Its last three reported values are -$286000.0 in Q3 2025, $351000.0 for Q2 2025, and -$917000.0 during Q1 2025.